King TA - Search Results

1

Is pleomorphic lobular carcinoma really a distinct clinical entity?

Buchanan CL, Flynn LW, Murray MP, Darvishian F, Cranor ML, Fey JV, King TA, Tan LK, Sclafani LM. Buchanan CL, et al. Among authors: king ta. J Surg Oncol. 2008 Oct 1;98(5):314-7. doi: 10.1002/jso.21121. J Surg Oncol. 2008. PMID: 18668643

2

A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.

King TA, Fey JV, Van Zee KJ, Heerdt AS, Gemignani ML, Port ER, Sclafani L, Sacchini V, Petrek JA, Cody HS 3rd, Borgen PI, Montgomery LL. King TA, et al. Ann Surg Oncol. 2004 May;11(5):535-41. doi: 10.1245/ASO.2004.10.014. Ann Surg Oncol. 2004. PMID: 15123464 Clinical Trial.

3

Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.

King TA, Ganaraj A, Fey JV, Tan LK, Hudis C, Norton L, Cody HS 3rd, Borgen PI. King TA, et al. Cancer. 2004 Sep 1;101(5):926-33. doi: 10.1002/cncr.20517. Cancer. 2004. PMID: 15329899 Free article.

4

Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter?

Wright MJ, Park J, Fey JV, Park A, O'Neill A, Tan LK, Borgen PI, Cody HS 3rd, Van Zee KJ, King TA. Wright MJ, et al. Among authors: king ta. J Am Coll Surg. 2007 Apr;204(4):541-9. doi: 10.1016/j.jamcollsurg.2007.01.031. J Am Coll Surg. 2007. PMID: 17382212

5

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J. King TA, et al. Ann Surg Oncol. 2007 Sep;14(9):2510-8. doi: 10.1245/s10434-007-9372-1. Epub 2007 Jun 29. Ann Surg Oncol. 2007. PMID: 17597348

6

MRI screening in a clinic population with a family history of breast cancer.

Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA. Yu J, et al. Among authors: king ta. Ann Surg Oncol. 2008 Feb;15(2):452-61. doi: 10.1245/s10434-007-9622-2. Epub 2007 Nov 17. Ann Surg Oncol. 2008. PMID: 18026801

7

Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?

McLaughlin SA, Stempel M, Morris EA, Liberman L, King TA. McLaughlin SA, et al. Among authors: king ta. Cancer. 2008 Mar 15;112(6):1214-21. doi: 10.1002/cncr.23298. Cancer. 2008. PMID: 18257089 Free article.

8

Presenting features of breast cancer differ by molecular subtype.

Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Wiechmann L, et al. Ann Surg Oncol. 2009 Oct;16(10):2705-10. doi: 10.1245/s10434-009-0606-2. Epub 2009 Jul 11. Ann Surg Oncol. 2009. PMID: 19593632

9

Impact of breast density on the presenting features of malignancy.

Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M. Arora N, et al. Among authors: king ta. Ann Surg Oncol. 2010 Oct;17 Suppl 3:211-8. doi: 10.1245/s10434-010-1237-3. Epub 2010 Sep 19. Ann Surg Oncol. 2010. PMID: 20853035

10

Selecting local therapy in the young breast cancer patient.

King TA. King TA. J Surg Oncol. 2011 Mar 15;103(4):330-6. doi: 10.1002/jso.21697. J Surg Oncol. 2011. PMID: 21337567 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters